News
New Ikarovec CSO Dr Katie Binley brings two decades of gene therapy expertise
Dr Peter Widdowson becomes CTO & company moves to Norwich Research Park Norwich, UK, July 29 2020 – Ikarovec, which is developing novel gene therapies to...
Read MoreIkarovec awarded grant by Innovate UK to develop new wet AMD gene therapy UKI2S Accelerator funding leverages recent investment & advances pipeline
Norwich, June 15 2020 – Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has been awarded £458,740 by Innovate UK, the...
Read MoreIkarovec completes £2.5 million seed funding round.
Ikarovec completes £2.5 million seed funding round. For further details see attachment